RAC 3.77% $1.53 race oncology ltd

AGM 2020 Video, page-4

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29638
    Breast Cancer -

    "it's become increasingly recognised as a problem with damage to the heart of patients given
    chemotherapeutics particularly those given anthracyclines or those given some of the newer or those given some of the newer monoclonals like Herceptin and those patients are going on to be cured of their cancer and then dying later on of heart failure and from many from the patient's perspective that's not necessarily a great win you really want to be able to treat patients cure them with their cancer and not leave them debilitated with heart failure and a slow painful death"

    See my posts on heart problems of existing chemotherapeutics:
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.